New diabetes clinical trial: A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China

Published on: 2026-03-06T05:00:00Z
Conditions: Type 2 Diabetes
Sponsors: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/2t5yTio